Click for best price
Oncology & Cancer Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 88290 million
|
Forecast Market size by 2030 |
US$ 123890 million
|
| Growth Rate |
CAGR of 4.5% |
Number of Pages |
122 Pages |
The global Oncology & Cancer Drugs market was valued at US$ 88290 million in 2023 and is projected to reach US$ 123890 million by 2030, at a CAGR of 4.5% during the forecast period.
The USA market for Global Oncology & Cancer Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Oncology & Cancer Drugsr market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Oncology & Cancer Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Oncology & Cancer Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oncology & Cancer Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oncology & Cancer Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Oncology & Cancer Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oncology & Cancer Drugs market presents opportunities for various stakeholders, including Blood Cancer, Breast Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oncology & Cancer Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Oncology & Cancer Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oncology & Cancer Drugs market.
Market Overview: The report provides a comprehensive overview of the Oncology & Cancer Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antimetabolite, Alkaloid drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oncology & Cancer Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oncology & Cancer Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oncology & Cancer Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Oncology & Cancer Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oncology & Cancer Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oncology & Cancer Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oncology & Cancer Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oncology & Cancer Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Oncology & Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Antimetabolite
- Alkaloid drugs
- Hormone
- Targeted drug
- Platinum-based drugs
- Other
Market segment by Application
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other
Global Oncology & Cancer Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Roche
- HENGRUI
- AstraZeneca
- QILU
- Sanofi
- HANSOH
- LUYE
- Novartis
- GuiZhou YiBai
- Lunan
- Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology & Cancer Drugs, market overview.
Chapter 2: Global Oncology & Cancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology & Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology & Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology & Cancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Oncology & Cancer Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 88290 million
|
| Forecast Market size by 2030 |
US$ 123890 million
|
| Growth Rate |
CAGR of 4.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
122 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology & Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology & Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology & Cancer Drugs Overall Market Size
2.1 Global Oncology & Cancer Drugs Market Size: 2023 VS 2030
2.2 Global Oncology & Cancer Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Oncology & Cancer Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Oncology & Cancer Drugs Players in Global Market
3.2 Top Global Oncology & Cancer Drugs Companies Ranked by Revenue
3.3 Global Oncology & Cancer Drugs Revenue by Companies
3.4 Global Oncology & Cancer Drugs Sales by Companies
3.5 Global Oncology & Cancer Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Oncology & Cancer Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Oncology & Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology & Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oncology & Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology & Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology & Cancer Drugs Market Size Markets, 2023 & 2030
4.1.2 Antimetabolite
4.1.3 Alkaloid drugs
4.1.4 Hormone
4.1.5 Targeted drug
4.1.6 Platinum-based drugs
4.1.7 Other
4.2 By Type - Global Oncology & Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Oncology & Cancer Drugs Revenue, 2019-2024
4.2.2 By Type - Global Oncology & Cancer Drugs Revenue, 2025-2030
4.2.3 By Type - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Oncology & Cancer Drugs Sales & Forecasts
4.3.1 By Type - Global Oncology & Cancer Drugs Sales, 2019-2024
4.3.2 By Type - Global Oncology & Cancer Drugs Sales, 2025-2030
4.3.3 By Type - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Oncology & Cancer Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology & Cancer Drugs Market Size, 2023 & 2030
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Other
5.2 By Application - Global Oncology & Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Oncology & Cancer Drugs Revenue, 2019-2024
5.2.2 By Application - Global Oncology & Cancer Drugs Revenue, 2025-2030
5.2.3 By Application - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Oncology & Cancer Drugs Sales & Forecasts
5.3.1 By Application - Global Oncology & Cancer Drugs Sales, 2019-2024
5.3.2 By Application - Global Oncology & Cancer Drugs Sales, 2025-2030
5.3.3 By Application - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Oncology & Cancer Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Oncology & Cancer Drugs Market Size, 2023 & 2030
6.2 By Region - Global Oncology & Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Oncology & Cancer Drugs Revenue, 2019-2024
6.2.2 By Region - Global Oncology & Cancer Drugs Revenue, 2025-2030
6.2.3 By Region - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Oncology & Cancer Drugs Sales & Forecasts
6.3.1 By Region - Global Oncology & Cancer Drugs Sales, 2019-2024
6.3.2 By Region - Global Oncology & Cancer Drugs Sales, 2025-2030
6.3.3 By Region - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Oncology & Cancer Drugs Revenue, 2019-2030
6.4.2 By Country - North America Oncology & Cancer Drugs Sales, 2019-2030
6.4.3 US Oncology & Cancer Drugs Market Size, 2019-2030
6.4.4 Canada Oncology & Cancer Drugs Market Size, 2019-2030
6.4.5 Mexico Oncology & Cancer Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Oncology & Cancer Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Oncology & Cancer Drugs Sales, 2019-2030
6.5.3 Germany Oncology & Cancer Drugs Market Size, 2019-2030
6.5.4 France Oncology & Cancer Drugs Market Size, 2019-2030
6.5.5 U.K. Oncology & Cancer Drugs Market Size, 2019-2030
6.5.6 Italy Oncology & Cancer Drugs Market Size, 2019-2030
6.5.7 Russia Oncology & Cancer Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Oncology & Cancer Drugs Market Size, 2019-2030
6.5.9 Benelux Oncology & Cancer Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Oncology & Cancer Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Oncology & Cancer Drugs Sales, 2019-2030
6.6.3 China Oncology & Cancer Drugs Market Size, 2019-2030
6.6.4 Japan Oncology & Cancer Drugs Market Size, 2019-2030
6.6.5 South Korea Oncology & Cancer Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Oncology & Cancer Drugs Market Size, 2019-2030
6.6.7 India Oncology & Cancer Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Oncology & Cancer Drugs Revenue, 2019-2030
6.7.2 By Country - South America Oncology & Cancer Drugs Sales, 2019-2030
6.7.3 Brazil Oncology & Cancer Drugs Market Size, 2019-2030
6.7.4 Argentina Oncology & Cancer Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oncology & Cancer Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Oncology & Cancer Drugs Sales, 2019-2030
6.8.3 Turkey Oncology & Cancer Drugs Market Size, 2019-2030
6.8.4 Israel Oncology & Cancer Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Oncology & Cancer Drugs Market Size, 2019-2030
6.8.6 UAE Oncology & Cancer Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology & Cancer Drugs Major Product Offerings
7.1.4 Roche Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 HENGRUI
7.2.1 HENGRUI Company Summary
7.2.2 HENGRUI Business Overview
7.2.3 HENGRUI Oncology & Cancer Drugs Major Product Offerings
7.2.4 HENGRUI Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.2.5 HENGRUI Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Oncology & Cancer Drugs Major Product Offerings
7.3.4 AstraZeneca Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 QILU
7.4.1 QILU Company Summary
7.4.2 QILU Business Overview
7.4.3 QILU Oncology & Cancer Drugs Major Product Offerings
7.4.4 QILU Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.4.5 QILU Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Oncology & Cancer Drugs Major Product Offerings
7.5.4 Sanofi Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 HANSOH
7.6.1 HANSOH Company Summary
7.6.2 HANSOH Business Overview
7.6.3 HANSOH Oncology & Cancer Drugs Major Product Offerings
7.6.4 HANSOH Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.6.5 HANSOH Key News & Latest Developments
7.7 LUYE
7.7.1 LUYE Company Summary
7.7.2 LUYE Business Overview
7.7.3 LUYE Oncology & Cancer Drugs Major Product Offerings
7.7.4 LUYE Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.7.5 LUYE Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Oncology & Cancer Drugs Major Product Offerings
7.8.4 Novartis Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 GuiZhou YiBai
7.9.1 GuiZhou YiBai Company Summary
7.9.2 GuiZhou YiBai Business Overview
7.9.3 GuiZhou YiBai Oncology & Cancer Drugs Major Product Offerings
7.9.4 GuiZhou YiBai Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.9.5 GuiZhou YiBai Key News & Latest Developments
7.10 Lunan
7.10.1 Lunan Company Summary
7.10.2 Lunan Business Overview
7.10.3 Lunan Oncology & Cancer Drugs Major Product Offerings
7.10.4 Lunan Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Lunan Key News & Latest Developments
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Company Summary
7.11.2 Eli Lilly and Company Business Overview
7.11.3 Eli Lilly and Company Oncology & Cancer Drugs Major Product Offerings
7.11.4 Eli Lilly and Company Oncology & Cancer Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Eli Lilly and Company Key News & Latest Developments
8 Global Oncology & Cancer Drugs Production Capacity, Analysis
8.1 Global Oncology & Cancer Drugs Production Capacity, 2019-2030
8.2 Oncology & Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology & Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology & Cancer Drugs Supply Chain Analysis
10.1 Oncology & Cancer Drugs Industry Value Chain
10.2 Oncology & Cancer Drugs Upstream Market
10.3 Oncology & Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology & Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Oncology & Cancer Drugs in Global Market
Table 2. Top Oncology & Cancer Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Oncology & Cancer Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Oncology & Cancer Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Oncology & Cancer Drugs Sales by Companies, (K MT), 2019-2024
Table 6. Global Oncology & Cancer Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Oncology & Cancer Drugs Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Oncology & Cancer Drugs Product Type
Table 9. List of Global Tier 1 Oncology & Cancer Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology & Cancer Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Oncology & Cancer Drugs Sales (K MT), 2019-2024
Table 15. By Type - Global Oncology & Cancer Drugs Sales (K MT), 2025-2030
Table 16. By Application ? Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Oncology & Cancer Drugs Sales (K MT), 2019-2024
Table 20. By Application - Global Oncology & Cancer Drugs Sales (K MT), 2025-2030
Table 21. By Region ? Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Oncology & Cancer Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Oncology & Cancer Drugs Sales (K MT), 2019-2024
Table 25. By Region - Global Oncology & Cancer Drugs Sales (K MT), 2025-2030
Table 26. By Country - North America Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Oncology & Cancer Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Oncology & Cancer Drugs Sales, (K MT), 2019-2024
Table 29. By Country - North America Oncology & Cancer Drugs Sales, (K MT), 2025-2030
Table 30. By Country - Europe Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Oncology & Cancer Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Oncology & Cancer Drugs Sales, (K MT), 2019-2024
Table 33. By Country - Europe Oncology & Cancer Drugs Sales, (K MT), 2025-2030
Table 34. By Region - Asia Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Oncology & Cancer Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Oncology & Cancer Drugs Sales, (K MT), 2019-2024
Table 37. By Region - Asia Oncology & Cancer Drugs Sales, (K MT), 2025-2030
Table 38. By Country - South America Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Oncology & Cancer Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Oncology & Cancer Drugs Sales, (K MT), 2019-2024
Table 41. By Country - South America Oncology & Cancer Drugs Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Oncology & Cancer Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Oncology & Cancer Drugs Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Oncology & Cancer Drugs Sales, (K MT), 2025-2030
Table 46. Roche Company Summary
Table 47. Roche Oncology & Cancer Drugs Product Offerings
Table 48. Roche Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. Roche Key News & Latest Developments
Table 50. HENGRUI Company Summary
Table 51. HENGRUI Oncology & Cancer Drugs Product Offerings
Table 52. HENGRUI Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. HENGRUI Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Oncology & Cancer Drugs Product Offerings
Table 56. AstraZeneca Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. QILU Company Summary
Table 59. QILU Oncology & Cancer Drugs Product Offerings
Table 60. QILU Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. QILU Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Oncology & Cancer Drugs Product Offerings
Table 64. Sanofi Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. HANSOH Company Summary
Table 67. HANSOH Oncology & Cancer Drugs Product Offerings
Table 68. HANSOH Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. HANSOH Key News & Latest Developments
Table 70. LUYE Company Summary
Table 71. LUYE Oncology & Cancer Drugs Product Offerings
Table 72. LUYE Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. LUYE Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Oncology & Cancer Drugs Product Offerings
Table 76. Novartis Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. Novartis Key News & Latest Developments
Table 78. GuiZhou YiBai Company Summary
Table 79. GuiZhou YiBai Oncology & Cancer Drugs Product Offerings
Table 80. GuiZhou YiBai Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. GuiZhou YiBai Key News & Latest Developments
Table 82. Lunan Company Summary
Table 83. Lunan Oncology & Cancer Drugs Product Offerings
Table 84. Lunan Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. Lunan Key News & Latest Developments
Table 86. Eli Lilly and Company Company Summary
Table 87. Eli Lilly and Company Oncology & Cancer Drugs Product Offerings
Table 88. Eli Lilly and Company Oncology & Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 89. Eli Lilly and Company Key News & Latest Developments
Table 90. Oncology & Cancer Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 91. Global Oncology & Cancer Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 92. Global Oncology & Cancer Drugs Production by Region, 2019-2024 (K MT)
Table 93. Global Oncology & Cancer Drugs Production by Region, 2025-2030 (K MT)
Table 94. Oncology & Cancer Drugs Market Opportunities & Trends in Global Market
Table 95. Oncology & Cancer Drugs Market Drivers in Global Market
Table 96. Oncology & Cancer Drugs Market Restraints in Global Market
Table 97. Oncology & Cancer Drugs Raw Materials
Table 98. Oncology & Cancer Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Oncology & Cancer Drugs Downstream
Table 100. Oncology & Cancer Drugs Downstream Clients in Global Market
Table 101. Oncology & Cancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oncology & Cancer Drugs Segment by Type in 2023
Figure 2. Oncology & Cancer Drugs Segment by Application in 2023
Figure 3. Global Oncology & Cancer Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Oncology & Cancer Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Oncology & Cancer Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Oncology & Cancer Drugs Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Oncology & Cancer Drugs Revenue in 2023
Figure 9. By Type - Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Oncology & Cancer Drugs Price (USD/MT), 2019-2030
Figure 13. By Application - Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Oncology & Cancer Drugs Price (USD/MT), 2019-2030
Figure 17. By Region - Global Oncology & Cancer Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Oncology & Cancer Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 23. US Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 28. Germany Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 37. China Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Oncology & Cancer Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Oncology & Cancer Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Oncology & Cancer Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Oncology & Cancer Drugs Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Oncology & Cancer Drugs by Region, 2023 VS 2030
Figure 54. Oncology & Cancer Drugs Industry Value Chain
Figure 55. Marketing Channels
